Adam Zarren, George Petrocheilos, Wendy Morris, Beth McGinn and Renee Jenkins | Kennedy Krieger Institute

Top row, from left, Adam Zarren and George Petrocheilos; Second row, Wendy Morris and Beth McGuinn; Third row, Renee Jenkins

Top row, from left, Adam Zarren and George Petrocheilos; Second row, Wendy Morris and Beth McGuinn; Third row, Renee Jenkins

Adam Zarren, George Petrocheilos, Wendy Morris, Beth McGinn and Renee Jenkins, MD, FAAP were named to the board of directors of the Kennedy Krieger Institute.

Zarren is the founder and managing partner of the Zarren Law Group LLC, where he serves as an m&a/business/corporate/transactional attorney who advises businesses, C-level executives, business owners and their families, and other entrepreneurs on legal matters that take into consideration both their business goals and personal wealth targets. Prior to founding ZLG, he was a partner at Saul Ewing LLP and a partner at Neuberger, Quinn, Gielen, Rubin and Gibber, P.A. He has also authored many publications on business law and M&A locally, nationally and internationally. Zarren currently serves as an advisory member of Betamore, a Baltimore-based technology incubator.

Petrocheilos is a partner at Camden Partners Holdings LLC and the co-founder of Camden Partners Nexus, the firm’s venture capital strategy. He currently sits on the board of Sisu Global Health Inc., WindMIL Therapeutics, Ashvattha Therapeutics, Cage Pharmaceuticals and eNeura, Inc. in addition to the family-owned PETKA S.A., a construction and development company headquartered in Athens, Greece. He also serves on the board of trustees of The Baltimore School for the Arts, The Johns Hopkins Center for Financial Economics, The Johns Hopkins Medicine Psychiatry and Behavioral Sciences Advisory Board and the Director’s Circle of the Greater Baltimore Cultural Alliance.

Morris is a retired attorney and active member of the autism community. With the goal of continuing to support her son who has autism, Morris has dedicated her time to not only caring and advocating for her son but also supporting organizations serving the special needs community. Morris’ more than 11 years of law experience spans the banking and finance industry and includes positions at Muldoon, Murphy & Faucette and Mayer, Brown & Platt where she negotiated merger transactional agreements, researched and advised on regulatory matters and prepared corporate and compliance documents for financial institutions.

McGinn serves as co-founder and executive director of the nonprofit organization A Cure for Ellie, named for her daughter, Ellie McGinn, who was diagnosed with a progressive and very rare genetic disorder, Leukoencephalopathy with Brainstem and Spinal Cord Involvement and Lactate Elevation (LBSL), in 2011 at age three. Through A Cure for Ellie, the McGinns have been integral in raising funds for LBSL research at Kennedy Krieger, where her daughter receives treatment. Prior to A Cure for Ellie, McGinn worked on Capitol Hill as a communications director and spokesperson for several members of the U.S. House of Representatives and the House Judiciary Committee.

Jenkins is a professor and chair emerita in the Department of Pediatrics and Child Health at Howard University and an adjunct professor of Pediatrics at George Washington University. After completing her fellowship in Adolescent Medicine at Montefiore Hospital in New York, Jenkins started an adolescent medicine program at Howard University and was eventually appointed department chair of Pediatrics. From 2007 to 2008, Jenkins served as national president of the American Academy of Pediatrics.

Information in Movers and Shakers is provided by the submitter. To submit a Movers and Shakers item, visit https://thedailyrecord.com/movers/.

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *